'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
15 Jul 2022
Historique:
received: 02 05 2021
accepted: 29 06 2022
entrez: 15 7 2022
pubmed: 16 7 2022
medline: 20 7 2022
Statut: epublish

Résumé

Many women in sub-Saharan Africa initiate antenatal care (ANC) late in pregnancy, undermining optimal prevention of mother-to-child-transmission (PMTCT) of HIV. Questions remain about whether and how late initiation of ANC in pregnancy is related to adherence to antiretroviral therapy (ART) in the era of national dolutegravir roll-out. This study employed a qualitative design involving individual interviews and focus group discussions conducted between August 2018 and March 2019. We interviewed 37 pregnant and lactating women living with HIV selected purposively for early or late presentation to ANC from poor urban communities in South Africa and Uganda. Additionally, we carried out seven focused group discussions involving 67 participants in both countries. Data were analysed thematically in NVivo12. Women described common underlying factors influencing both late ANC initiation and poor ART adherence in South Africa and Uganda. These included poverty and time constraints; inadequate health knowledge; perceived low health risk; stigma of HIV in pregnancy; lack of disclosure; and negative provider attitudes. Most late ANC presenters reported relationship problems, lack of autonomy and the limited ability to dialogue with their partners to influence household decisions on health and resource allocation. Perception of poor privacy and confidentiality in maternity clinics was rife among women in both study settings and compounded risks associated with early disclosure of pregnancy and HIV. Women who initiated ANC late and were then diagnosed with HIV appeared to be more susceptible to poor ART adherence. They were often reprimanded by health workers for presenting late which hampered their participation in treatment counselling and festered provider mistrust and subsequent disengagement in care. Positive HIV diagnosis in late pregnancy complicated women's ability to disclose their status to significant others which deprived them of essential social support for treatment adherence. Further, it appeared to adversely affect women's mental health and treatment knowledge and self-efficacy. We found clear links between late initiation of ANC and the potential for poor adherence to ART based on common structural barriers shaping both health seeking behaviours, and the adverse impact of late HIV diagnosis on women's mental health and treatment knowledge and efficacy. Women who present late are a potential target group for better access to antiretrovirals that are easy to take and decrease viral load rapidly, and counselling support with adherence and partner disclosure. A combination of strengthened health literacy, economic empowerment, improved privacy and patient-provider relationships as well as community interventions that tackle inimical cultural practices on pregnancy and unfair gender norms may be required.

Sections du résumé

BACKGROUND BACKGROUND
Many women in sub-Saharan Africa initiate antenatal care (ANC) late in pregnancy, undermining optimal prevention of mother-to-child-transmission (PMTCT) of HIV. Questions remain about whether and how late initiation of ANC in pregnancy is related to adherence to antiretroviral therapy (ART) in the era of national dolutegravir roll-out.
METHODS METHODS
This study employed a qualitative design involving individual interviews and focus group discussions conducted between August 2018 and March 2019. We interviewed 37 pregnant and lactating women living with HIV selected purposively for early or late presentation to ANC from poor urban communities in South Africa and Uganda. Additionally, we carried out seven focused group discussions involving 67 participants in both countries. Data were analysed thematically in NVivo12.
RESULTS RESULTS
Women described common underlying factors influencing both late ANC initiation and poor ART adherence in South Africa and Uganda. These included poverty and time constraints; inadequate health knowledge; perceived low health risk; stigma of HIV in pregnancy; lack of disclosure; and negative provider attitudes. Most late ANC presenters reported relationship problems, lack of autonomy and the limited ability to dialogue with their partners to influence household decisions on health and resource allocation. Perception of poor privacy and confidentiality in maternity clinics was rife among women in both study settings and compounded risks associated with early disclosure of pregnancy and HIV. Women who initiated ANC late and were then diagnosed with HIV appeared to be more susceptible to poor ART adherence. They were often reprimanded by health workers for presenting late which hampered their participation in treatment counselling and festered provider mistrust and subsequent disengagement in care. Positive HIV diagnosis in late pregnancy complicated women's ability to disclose their status to significant others which deprived them of essential social support for treatment adherence. Further, it appeared to adversely affect women's mental health and treatment knowledge and self-efficacy.
CONCLUSIONS CONCLUSIONS
We found clear links between late initiation of ANC and the potential for poor adherence to ART based on common structural barriers shaping both health seeking behaviours, and the adverse impact of late HIV diagnosis on women's mental health and treatment knowledge and efficacy. Women who present late are a potential target group for better access to antiretrovirals that are easy to take and decrease viral load rapidly, and counselling support with adherence and partner disclosure. A combination of strengthened health literacy, economic empowerment, improved privacy and patient-provider relationships as well as community interventions that tackle inimical cultural practices on pregnancy and unfair gender norms may be required.

Identifiants

pubmed: 35840939
doi: 10.1186/s12884-022-04896-5
pii: 10.1186/s12884-022-04896-5
pmc: PMC9284724
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

566

Subventions

Organisme : Unitaid
ID : 2016-08-UoL
Organisme : Unitaid
ID : 2016-08-UoL
Organisme : Unitaid
ID : 2016-08-UoL
Organisme : Unitaid
ID : 2016-08-UoL
Organisme : Unitaid
ID : 2016-08-UoL
Organisme : Unitaid
ID : 2016-08-UoL
Organisme : Unitaid
ID : 2016-08-UoL
Organisme : Unitaid
ID : 2016-08-UoL
Organisme : Unitaid
ID : 2016-08-UoL
Organisme : Unitaid
ID : 2016-08-UoL

Informations de copyright

© 2022. The Author(s).

Références

BMC Pregnancy Childbirth. 2017 Mar 21;17(1):94
pubmed: 28320347
J Midwifery Womens Health. 2003 Jul-Aug;48(4):268-72
pubmed: 12867911
BMJ Glob Health. 2019 Nov 25;4(6):e001788
pubmed: 31803509
Soc Sci Med. 2003 Jul;57(2):355-74
pubmed: 12765714
Sex Reprod Healthc. 2020 Mar;23:100464
pubmed: 31710878
J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):276-81
pubmed: 18845949
Matern Child Health J. 2013 Feb;17(2):359-67
pubmed: 22527767
Soc Sci Med. 2018 May;205:82-89
pubmed: 29674017
BMC Health Serv Res. 2019 Dec 30;19(1):1016
pubmed: 31888616
Int J Gynaecol Obstet. 2016 Jan;132(1):64-7
pubmed: 26439856
Lancet HIV. 2020 May;7(5):e332-e339
pubmed: 32386721
BMC Health Serv Res. 2020 Aug 1;20(1):705
pubmed: 32738918
Reprod Health. 2016 Jun 08;13 Suppl 1:32
pubmed: 27356754
BMJ Open. 2019 Oct 7;9(10):e031890
pubmed: 31594900
BMC Public Health. 2020 Dec 7;20(1):1883
pubmed: 33287795
J Family Reprod Health. 2015 Jun;9(2):65-73
pubmed: 26175761
AIDS Care. 2011 Feb;23(2):146-51
pubmed: 21259126
Soc Sci Med. 2008 Mar;66(5):1106-17
pubmed: 18166257
J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):e33-8
pubmed: 25501608
Reprod Health. 2013 Aug 20;10:40
pubmed: 23962135
PLoS One. 2018 Jun 11;13(6):e0197979
pubmed: 29889849
BMC Public Health. 2018 Jun 27;18(1):805
pubmed: 29945601
BMC Infect Dis. 2018 Apr 13;18(1):175
pubmed: 29653510
BMC Pregnancy Childbirth. 2015 Nov 04;15:287
pubmed: 26538084
Am J Health Promot. 1996 Mar-Apr;10(4):282-98
pubmed: 10159709
BMC Pregnancy Childbirth. 2013 May 25;13:121
pubmed: 23706142
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
AIDS Care. 2011 Jun;23(6):741-7
pubmed: 21293987
J Acquir Immune Defic Syndr. 2014 Dec 1;67 Suppl 4:S195-201
pubmed: 25436818
Health Policy Plan. 2019 Oct 1;34(8):566-573
pubmed: 31408150
J Health Soc Behav. 1972 Dec;13(4):369-82
pubmed: 4648892
BMC Pregnancy Childbirth. 2012 Sep 11;12:94
pubmed: 22963318
PLoS Med. 2013;10(1):e1001373
pubmed: 23349622
J Med Ethics. 2005 May;31(5):299-303
pubmed: 15863692
J Int AIDS Soc. 2014 Oct 08;17:19242
pubmed: 25301494

Auteurs

Yussif Alhassan (Y)

Department of International Public Health, Liverpool School of Tropical Medicine, Pembroke Place, L3 5QA, Liverpool, UK. yussif.alhassan@lstmed.ac.uk.

Adelline Twimukye (A)

Infectious Diseases Institute, Makerere University, Kampala, Uganda.

Thokozile Malaba (T)

School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Landon Myer (L)

School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Catriona Waitt (C)

Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.

Mohammed Lamorde (M)

Infectious Diseases Institute, Makerere University, Kampala, Uganda.

Angela Colbers (A)

Radboud University Nijmegen Medical Centre, Radboud Institute for Health Sciences, Nijmegen, Netherlands.

Helen Reynolds (H)

Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.

Saye Khoo (S)

Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Tropical Infectious Diseases Unit, Liverpool University Hospitals Foundation Trust, Liverpool, UK.

Miriam Taegtmeyer (M)

Tropical Infectious Diseases Unit, Liverpool University Hospitals Foundation Trust, Liverpool, UK.
Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH